SPR Therapeutics, a Cleveland, Ohio firm, landed clearance from the FDA for its SPRINT endura and extensa peripheral nerve stimulators (PNS). The endura is a single lead system, while the extensa is dual lead. The two devices represent the only FDA cleared dual-lead capable percutaneous PNS that can be used for up to two m (Read more...)